136 related articles for article (PubMed ID: 22293788)
21. Microsatellite instability-low colorectal cancer acquires a KRAS mutation during the progression from Dukes' A to Dukes' B.
Asaka S; Arai Y; Nishimura Y; Yamaguchi K; Ishikubo T; Yatsuoka T; Tanaka Y; Akagi K
Carcinogenesis; 2009 Mar; 30(3):494-9. PubMed ID: 19147861
[TBL] [Abstract][Full Text] [Related]
22. Development of sporadic microsatellite instability in colorectal tumors involves hypermethylation at methylated-in-tumor loci in adenoma.
de Maat MF; Narita N; Benard A; Yoshimura T; Kuo C; Tollenaar RA; de Miranda NF; Turner RR; van de Velde CJ; Morreau H; Hoon DS
Am J Pathol; 2010 Nov; 177(5):2347-56. PubMed ID: 20952593
[TBL] [Abstract][Full Text] [Related]
23. Combined methylation of p16 and hMLH1 (CMETH2) discriminates a subpopulation with better prognosis in colorectal cancer patients with microsatellite instability tumors.
Veganzones S; Maestro ML; Rafael S; de la Orden V; Vidaurreta M; Mediero B; Espantaleón M; Cerdán J; Díaz-Rubio E
Tumour Biol; 2015 May; 36(5):3853-61. PubMed ID: 25576161
[TBL] [Abstract][Full Text] [Related]
24. Role of BRAF-V600E in the serrated pathway of colorectal tumourigenesis.
Minoo P; Moyer MP; Jass JR
J Pathol; 2007 Jun; 212(2):124-33. PubMed ID: 17427169
[TBL] [Abstract][Full Text] [Related]
25. High concordance rate of KRAS/BRAF mutations and MSI-H between primary colorectal cancer and corresponding metastases.
Fujiyoshi K; Yamamoto G; Takahashi A; Arai Y; Yamada M; Kakuta M; Yamaguchi K; Akagi Y; Nishimura Y; Sakamoto H; Akagi K
Oncol Rep; 2017 Feb; 37(2):785-792. PubMed ID: 28000889
[TBL] [Abstract][Full Text] [Related]
26. Molecular profile and copy number analysis of sporadic colorectal cancer in Taiwan.
Lin CH; Lin JK; Chang SC; Chang YH; Chang HM; Liu JH; Li LH; Chen YT; Tsai SF; Chen WS
J Biomed Sci; 2011 Jun; 18(1):36. PubMed ID: 21645411
[TBL] [Abstract][Full Text] [Related]
27. Mutations of BRAF are associated with extensive hMLH1 promoter methylation in sporadic colorectal carcinomas.
Koinuma K; Shitoh K; Miyakura Y; Furukawa T; Yamashita Y; Ota J; Ohki R; Choi YL; Wada T; Konishi F; Nagai H; Mano H
Int J Cancer; 2004 Jan; 108(2):237-42. PubMed ID: 14639609
[TBL] [Abstract][Full Text] [Related]
28. Annexin A10 expression correlates with serrated pathway features in colorectal carcinoma with microsatellite instability.
Kim JH; Rhee YY; Kim KJ; Cho NY; Lee HS; Kang GH
APMIS; 2014 Dec; 122(12):1187-95. PubMed ID: 24909058
[TBL] [Abstract][Full Text] [Related]
29. Mutations in the WTX-gene are found in some high-grade microsatellite instable (MSI-H) colorectal cancers.
Scheel SK; Porzner M; Pfeiffer S; Ormanns S; Kirchner T; Jung A
BMC Cancer; 2010 Aug; 10():413. PubMed ID: 20696052
[TBL] [Abstract][Full Text] [Related]
30. Serrated pathway adenocarcinomas: molecular and immunohistochemical insights into their recognition.
Gurzu S; Szentirmay Z; Toth E; Bara T; Bara T; Jung I
PLoS One; 2013; 8(3):e57699. PubMed ID: 23469219
[TBL] [Abstract][Full Text] [Related]
31. Distinction of hereditary nonpolyposis colorectal cancer and sporadic microsatellite-unstable colorectal cancer through quantification of MLH1 methylation by real-time PCR.
Bettstetter M; Dechant S; Ruemmele P; Grabowski M; Keller G; Holinski-Feder E; Hartmann A; Hofstaedter F; Dietmaier W
Clin Cancer Res; 2007 Jun; 13(11):3221-8. PubMed ID: 17545526
[TBL] [Abstract][Full Text] [Related]
32. Combined microsatellite instability and BRAF gene status as biomarkers for adjuvant chemotherapy in stage III colorectal cancer.
Ooki A; Akagi K; Yatsuoka T; Asayama M; Hara H; Takahashi A; Kakuta M; Nishimura Y; Yamaguchi K
J Surg Oncol; 2014 Dec; 110(8):982-8. PubMed ID: 25154726
[TBL] [Abstract][Full Text] [Related]
33. Epigenetics could explain some Moroccan population colorectal cancers peculiarities: microsatellite instability pathway exploration.
Sekal M; Ameurtesse H; Chbani L; Ouldim K; Bennis S; Abkari M; Boulouz A; Benajah DA; Benjelloun B; Ousadden A; Ait Taleb K; Ait Laalim S; Toghrai I; Mazaz K; Arifi S; Mellas N; El Rhazi K; Harmouch T; Ibrahimi SA; Amarti Riffi A
Diagn Pathol; 2015 Jun; 10():77. PubMed ID: 26104511
[TBL] [Abstract][Full Text] [Related]
34. Prognostic role of beta-catenin and p53 expression in the metastatic progression of sporadic colorectal cancer.
Pancione M; Forte N; Fucci A; Sabatino L; Febbraro A; Di Blasi A; Daniele B; Parente D; Colantuoni V
Hum Pathol; 2010 Jun; 41(6):867-76. PubMed ID: 20129645
[TBL] [Abstract][Full Text] [Related]
35. Multivariate analysis as a method for evaluating the pathogenicity of novel genetic MLH1 variants in patients with colorectal cancer and microsatellite instability.
Duraturo F; Liccardo R; Cavallo A; De Rosa M; Rossi GB; Izzo P
Int J Mol Med; 2015 Aug; 36(2):511-7. PubMed ID: 26096739
[TBL] [Abstract][Full Text] [Related]
36. Morphology and microsatellite instability in sporadic serrated and non-serrated colorectal cancer.
Tuppurainen K; Mäkinen JM; Junttila O; Liakka A; Kyllönen AP; Tuominen H; Karttunen TJ; Mäkinen MJ
J Pathol; 2005 Nov; 207(3):285-94. PubMed ID: 16177963
[TBL] [Abstract][Full Text] [Related]
37. Possible role of Cdx2 in the serrated pathway of colorectal cancer characterized by BRAF mutation, high-level CpG Island methylator phenotype and mismatch repair-deficiency.
Dawson H; Galván JA; Helbling M; Muller DE; Karamitopoulou E; Koelzer VH; Economou M; Hammer C; Lugli A; Zlobec I
Int J Cancer; 2014 May; 134(10):2342-51. PubMed ID: 24166180
[TBL] [Abstract][Full Text] [Related]
38. A high degree of LINE-1 hypomethylation is a unique feature of early-onset colorectal cancer.
Antelo M; Balaguer F; Shia J; Shen Y; Hur K; Moreira L; Cuatrecasas M; Bujanda L; Giraldez MD; Takahashi M; Cabanne A; Barugel ME; Arnold M; Roca EL; Andreu M; Castellvi-Bel S; Llor X; Jover R; Castells A; Boland CR; Goel A
PLoS One; 2012; 7(9):e45357. PubMed ID: 23049789
[TBL] [Abstract][Full Text] [Related]
39. The prognostic impact of CDX2 correlates with the underlying mismatch repair status and BRAF mutational status but not with distant metastasis in colorectal cancer.
Neumann J; Heinemann V; Engel J; Kirchner T; Stintzing S
Virchows Arch; 2018 Aug; 473(2):199-207. PubMed ID: 29675807
[TBL] [Abstract][Full Text] [Related]
40. Incorporation of somatic BRAF mutation testing into an algorithm for the investigation of hereditary non-polyposis colorectal cancer.
Loughrey MB; Waring PM; Tan A; Trivett M; Kovalenko S; Beshay V; Young MA; McArthur G; Boussioutas A; Dobrovic A
Fam Cancer; 2007; 6(3):301-10. PubMed ID: 17453358
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
